← Open Payments lookup

MICHAEL PREJEAN: Open Payments

NPI 1215087887 · MAMOU, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$421 in 22 payments from 7 companies in 2025. Trend: 2023 $580 · 2024 $291 · 2025 $421

Food & beverage: $421
CompanyPaymentsAmount
Alkermes, Inc.10$191
ABBVIE INC.4$82
Teva Pharmaceuticals USA, Inc.4$74
Vanda Pharmaceuticals Inc.1$27
Noven Therapeutics, LLC1$16
Janssen Pharmaceuticals, Inc1$16
Luye Pharma (USA) Ltd.1$15

Products named: ARISTADA, LYBALVI, VRAYLAR, UZEDY, FANAPT, Xelstrym, INVEGA SUSTENNA, ERZOFRI EXTENDED-RELEASE.

Industry payments across LA — which companies pay providers there.